The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1–selected populations.
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; Eutilex; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical
Speakers' Bureau - Amgen; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; Lilly; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks
 
Lucjan Wyrwicz
Honoraria - BeiGene; BMS; MSD
Consulting or Advisory Role - GlaxoSmithKline; SERVIER
Speakers' Bureau - BMS
Travel, Accommodations, Expenses - SERVIER
 
Patricio Eduardo Yanez Weber
Honoraria - AstraZeneca (Inst); BMS CHILE (Inst); MSD (Inst); Sanofi/Regeneron (Inst)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; MSD Oncology
Speakers' Bureau - AstraZeneca; BMS CHILE
 
Yuxian Bai
No Relationships to Disclose
 
Min-Hee Ryu
Honoraria - AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Jeeyun Lee
Consulting or Advisory Role - AstraZeneca; Guardant Health AMEA; Mirati Therapeutics; Oncologie; Trutino Biosciences
Research Funding - AstraZeneca; Merck Sharp & Dohme
 
Fernando Rivera
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Gilead Sciences; Lilly O.; Merck Serono; MSD; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Lilly O. (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst); Sanofi (Inst); SERVIER
Other Relationship - Member of steering committee of TTD group; President of FUPOCAN
 
Gustavo Vasconcelos Alves
Consulting or Advisory Role - AstraZeneca; Merck Serono; MSD Oncology
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Sanofi
Research Funding - AstraZeneca (Inst); AVEO (Inst); BeiGene (Inst); BMS Brazil (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Roche (Inst); Sanofi (Inst); Zymeworks (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Marcelo Garrido
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Roche
 
Kai-Keen Shiu
Honoraria - Daiichi Sankyo Europe GmbH; Innovent Biologics; Merck Serono; MSD Oncology; SERVIER
Consulting or Advisory Role - Mirati Therapeutics; MSD Oncology; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - MSD Oncology
 
Manuel González Fernández
No Relationships to Disclose
 
Jin Li
Honoraria - AstraZeneca; Bristol-Myers Squibb; HenRui; Lilly O.; MSD; Roche
 
Maeve Aine Lowery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; SERVIER
Research Funding - Astellas Pharma; Basilea; Exelixis; MSD
 
Timucin Cil
No Relationships to Disclose
 
Felipe Melo Cruz
Travel, Accommodations, Expenses - Janssen Oncology; Novartis
 
Shukui Qin
No Relationships to Disclose
 
Lina Yin
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Sonal Bordia
Employment - Merck
 
Pooja Bhagia
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Do-Youn Oh
Consulting or Advisory Role - Arcus Biosciences; ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; IQVIA; Merck Serono; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER